S
LIVE

Serial Number

79381826

Owner

Selectchemie AG

Attorney

Randolph E. Digges, III

Filing Date

Jul 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

S Trademark

Serial Number: 79381826 • Registration: 7574830

S is a trademark filed by Selectchemie AG on July 26, 2023. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Selectchemie AG (4 trademarks)

Etzelstrasse 42

Entity Type: 99

Trademark Details

Filing Date

July 26, 2023

Registration Date

November 26, 2024

Published for Opposition

September 24, 2024

Goods & Services

Transport services, namely, transportation of goods; packaging and storage of merchandise, in particular packaging, storage and transport of raw materials for the pharmaceutical and food industry as well as finished generic pharmaceutical products

Colors, dyes, colorants, namely, colorants and additives in the nature of coloring and dyes for the manufacture of foodstuffs and food supplements

Scientific and technological services, namely, development of generic medicine products; industrial analysis, quality control and authentication services, particularly for the pharmaceutical and nutritional industry in the fields of quality assurance and analysis, regulatory authorization and regulatory affairs

Pharmaceutical products, namely, cardiovascular pharmaceutical preparations, antimycotic agents, antifungal agents, anticoagulant agents, anticancer drugs, analgesics, anorexiants, anticonvulsants, antiemetics, anti-Parkinson's, anticarcinoma, anxiolytics, sedatives and hypnotics, cholinergic agonists, cholinesterase inhibitors, CNS stimulants, general anesthetics, muscle relaxants, oral hypoglycemic agents, oral antihyperglycemic agents, biguanides, sulfonylureas, meglitinides, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose co-transporter 2 (SGLT2) inhibitors, thiazolidinediones (TZDs), and alpha-glucosidase inhibitors; active substances (APIs), drug substance intermediates (DSIs) and excipients for medicines and pharmaceutical products, namely, active pharmaceutical ingredients and drug substance intermediates all being pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; medical and veterinary preparations for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; active substances and intermediate products for medical and veterinary preparations , namely, pharmaceutical preparations and substances for the treatment of amyloidosis, pulmonary hypertension, spinal muscular atrophy, oncological diseases and conditions, diseases and conditions of the central nervous system, and diabetes; dietetic foods and beverages for medical or veterinary purposes; food ingredients and additives being dietetic foods and beverages adapted for medical use; food for babies; ingredients and additives being food for babies food supplements for humans and animals; ingredients and additives being food supplements

Chemicals used in industry and science, in particular active substances, auxiliaries and intermediate products for chemicals and types of chemicals; chemicals used in industry, namely, for the cosmetics industry; excipients being inert bases for the manufacture of pharmaceutical preparations; excipients for use in the manufacture of medical and veterinary preparations

Cosmetic non-medicated products, namely, cosmetic preparations, make-up; body care and beauty products, namely, body and beauty care cosmetics

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 25, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 25, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2024 TROA
REFUSAL PROCESSED BY IB
May 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 29, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 28, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2023 REPR